CCL2 and COVID-19: Patients with severe COVID‐19 admitted to the intensive care unit were more likely to have proinflammatory cytokines such as IFN‐γ, IP‐10, MCP‐1, IL‐1β, IL‐4, and IL‐10.16, 76